SIGA Technologies rises on orders worth $13 mln for smallpox drug

SIGA Technologies

23/06/2022 13:34

** Drugmaker SIGA Technologies' shares  SIGA.O  rise 7.3% to
$13.35 premarket
    ** Co says it has received about $13 mln of procurement
orders for oral Tpoxx, its smallpox drug  urn:newsml:reuters.com:*:nL4N2YA2AO
    ** Orders from new international jurisdictions represent the
first procurements of oral Tpoxx directly in response to
evolving global monkeypox outbreak - SIGA
    ** Oral form of Tpoxx is approved in the U.S., Canada and
Europe for treatment of smallpox, while European approval also
includes treatment of monkeypox, cowpox and complications from
immunization with smallpox vaccine
    ** Stock was up 76.04% YTD as of last close

 (Reporting by Mrinalika Roy in Bengaluru)
 ((mrinalika.roy@thomsonreuters.com))